Acurx Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Acurx Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ACXP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001736243
Board of directors
-
Carl Sailer · DirectorSince 2023
-
David P. Luci · Director · President and CEOSince 2023
-
Jack H. Dean · DirectorSince 2023
-
James J. Donohue · DirectorSince 2023
-
Joseph C. Scodari · DirectorSince 2023
-
Robert J. Deluccia · DirectorSince 2023
-
Thomas L. Harrison · DirectorSince 2023
Chief executives
David P. Luci
· President and CEO
Dates unknown
Board connections
1 of this board's directors also sit on 2 other boards.
- via Thomas L. Harrison
- via Thomas L. Harrison
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 6, 2025 | Joseph C. Scodari Director | Open-market purchase | +24,631 | $1.02 | $25,124 |
| Jan 6, 2025 | Carl Sailer Director | Open-market purchase | +24,631 | $1.02 | $25,124 |
| Jan 6, 2025 | David P. Luci Director, Officer (President and CEO), 10% owner | Open-market purchase | +49,261 | $1.02 | $50,246 |
| Jan 6, 2025 | James J. Donohue Director | Open-market purchase | +9,852 | $1.02 | $10,049 |
| Jan 6, 2025 | Robert J. Deluccia Director, 10% owner | Open-market purchase | +49,261 | $1.02 | $50,246 |
| Jan 6, 2025 | Jack H. Dean Director | Open-market purchase | +9,852 | $1.02 | $10,049 |
| Jan 19, 2024 | Carl Sailer Director | Option exercise | +19,737 | $3.55 | $70,066 |
| Jan 3, 2024 | David P. Luci Director, Officer (President and CEO), 10% owner | Option exercise | +19,737 | $3.55 | $70,066 |
| Jan 3, 2024 | Robert J. Deluccia Director, 10% owner | Option exercise | +19,737 | $3.55 | $70,066 |
| Dec 22, 2023 | Robert J. Deluccia Director, 10% owner | Gift | −30,000 | — | — |
| Dec 12, 2023 | Robert J. Deluccia Director, 10% owner | Gift | −40,000 | — | — |
| Dec 2, 2021 | Robert J. Deluccia Director, 10% owner | Gift | −40,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.